dr. carol aghajanian on the angiogenesis inhibitor pazopanib in ovarian cancer
Published 11 years ago • 966 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
0:59
dr. carol aghajanian on clincal trial endpoints in ovarian cancer
-
1:15
dr. aghajanian discusses parp inhibitors for the treatment of ovarian cancer
-
0:50
dr. aghajanian discusses clinical trial endpoints in ovarian cancer
-
27:10
promising advances in low grade serous ovarian cancer
-
3:21
pazopanib delays progression of advanced ovarian cancer
-
6:18
esmo 2014: inhibition of parp, angiogenesis and immune checkpoints for ovarian cancer management
-
22:51
role of the anti-angiogenesis in ovarian cancer dr. thomas herzog day 1 2021
-
58:09
fertility preservation in young women with breast cancer
-
59:48
lowdown on low grade serous ovarian cancer: learn the latest
-
1:03:29
‘the role of the female reproductive tract microbiome in ivf’
-
1:15
dr. konner on parp inhibitors in ovarian cancer
-
20:14
role of anti-angiogenesis in ovarian cancer dr. thomas herzog
-
1:00:30
genetic identifiers in ovarian cancer diagnosis & treatment
-
3:48
targeted therapy in newly diagnosed advanced ovarian cancer
-
11:38
new ovarian cancer research and treatments | memorial sloan kettering
-
1:12
dr. muggia on targeted therapies for ovarian cancer
-
3:39
asco 2013: delayed relapse of advanced ovarian cancer when treating with pazopanib
-
2:22
dr. andreas du bois reviews maintenance pazopanib in ovarian cancer
-
31:42
ovarian cancer with artificial intelligence by richard gabriel, president of tumorgenesis, inc.
-
48:31
strategies for managing long term recurrent ovarian cancer
-
26:25
rare ovarian cancers: advances & updates
-
43:20
understanding immunotherapy and it's impact on ovarian cancer